Cognition Therapeutics, Inc. (CGTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 98.24M |
| Enterprise Value | 62.06M |
| P/E Ratio | -4.03 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.21 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.19 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.46 |
| Return On Equity | -0.51 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -23.25M |
| Net Income | -23.49M |
| Diluted EPS | -0.32 |
| Total Cash | 30.76M |
| Total Cash/Share | 0.32 |
| Total Debt | 489,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 6.68 |
| Book Value Per Share | 0.31 |
| 52-Week Change | -60.41 |
| 52-Week High | 1.81 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 0.86 |
| Moving Average 200 Days | 1.04 |
| Average Volume | 468,453 |
| Shares Outstanding | 95.1M |
| % Held by Institutions | 25.02 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |